Venlafaxine Hydrochloride
- Product NDC
- 50090-5255
- 11-digit product format
- 500905255
- Labeler code
- 50090
- Product ID
- 50090-5255_648451b0-a171-46df-9265-53c49854dad7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Venlafaxine Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA203332
- Marketing category
- ANDA
- Marketing start
- 2020-03-20
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5255-0 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 3 |
| 50090-5255-1 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5255 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 3 | Legacy NDC, 2 package rows | 20210115_659dff30-dd97-44b4-b9d9-b954403b7476.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5255-0 | 50090525500 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-5255-0) | 2020-10-15 | 0000-00-00 | No | No | Current |
| 50090-5255-1 | 50090525501 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-5255-1) | 2020-10-15 | 0000-00-00 | No | No | Current |